PTS Diagnostics signs national sales, distribution agreement with Cardinal Health
PTS Diagnostics (Indianapolis, Ind.) signed a national sales and distribution agreement with Cardinal Health (Dublin, Ohio). Cardinal Health would further extend PTS Diagnostics’ reach within healthcare IDNs, including physicians’ offices. PTS Diagnostics’ portfolio includes the CardioChek Plus analyzer and the A1CNow+ system. These handheld diagnostic devices allow users to quickly measure HbA1c, glucose, and generate a lipid (cholesterol) profile, all at the point of care.
Henry Schein Ebola Relief Fund opened in response to outbreak in West Africa
Henry Schein Inc (Melville, N.Y.) opened the Henry Schein Ebola Relief Fund to support relief efforts related to the Ebola outbreak in West Africa. The Henry Schein Ebola Relief Fund was established through the Henry Schein Cares Foundation to provide a way for Team Schein members and others interested in supporting relief efforts to contribute. Henry Schein will match all donations contributed to this fund by Team Schein members, and the proceeds will be applied directly and completely to Ebola relief efforts through the CDC’s (Atlanta, GA) CDC Foundation. Anyone wishing to contribute to the Ebola Relief Fund can make a donation by credit card through the Henry Schein Cares Foundation website at www.hscaresfoundation.org/.
Becton Dickinson & Co to acquire CareFusion Corp for $12.2B
Becton Dickinson & Co (BD) (Franklin Lakes, N.J.) signed a definitive agreement to acquire CareFusion Corp (San Diego, Calif.) for $12.2 billion in cash and stock. BD says it will pay a total of $58.00 a share – $49.00 in cash and 0.0777 of a share of BD for each share of CareFusion. BD shareholders will own around 92 percent of the combined company and CareFusion shareholders will own around eight percent. The transaction, which was unanimously approved by both companies’ boards of directors, is expected to provide double-digit earnings growth, on an adjusted basis, in the first full year and will be accretive to net earnings in FY 2018. The deal is subject to regulatory and CareFusion shareholder approvals and customary closing conditions, and expected to close in the first half of calendar year 2015